MORGAN STANLEY - Dec 31, 2024 SCHEDULE 13G Report for Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Symbol
APLS
Shares outstanding
125M shares
Disclosed Ownership
9.59M shares
Ownership
7.7%
Form type
SCHEDULE 13G
Date filed
2/3/2025, 01:09 PM
Date of event
Dec 31, 2024

Reporting Managers (2)